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                                     INTRODUCTION
“Pain is a more terrible lord of mankind than even death itself” said nobel laureate 
ALBERT SCHWEIZER. Pain has become the fifth vital sign and is now a critical focus 
of the patient.  The relief of pain has been the fundamental aspect of the practice of 
anaesthesiology.  Proper management of pain remains one of the most important and 
pressing responsibilities of the anaesthesiologist.
There is increasing evidence that optimal pain management can impact outcome 
beyond the intraoperative period.  Alleviation of postoperative pain may continue to 
improve clinical outcomes, hasten recovery, facilitate early mobilization and return to 
daily living.  Children suffer pain in the same way as adults though they may be unable 
to describe the pain or their subjective experiences.  Unfortunately, even when their pain 
is obvious, children frequently receive no treatment or inadequate treatment.
Pain  is  a  perception  that  is  far  more  complex  than  simple  transmission  of 
information  along  nerve  pathways  to  the  brain.   It  consists  of  a  component  of 
transmission of  pain sensation,  a  component  of  processing and evaluation by higher 
centers of the brain and a component of reaction to sensation.
The response to pain in children consists of behaviour, psychological and social 
changes.   The  cognitive  ability,  child’s  trust  of  caregivers  and  previous  painful 
experiences will influence this response.  The manner in which the family reacts to the 
stress of a child’s pain will also influence the response to pain.
Appropriate pain management is of great importance when dealing with children, 
because the way the child is treated may influence the way he or she deals with pain for 
the  rest  of  his  or  her  life.   Untreated  pain  can  lead  to  physiological  complications, 
psychological distress and personality changes in developing children, family disruption 
and prolongation of hospital stay with resultant increased expenses.  In addition social 
withdrawal, temper tantrums and autistic behaviour are also seen in these children.
Various  pharmacological  agents  and  analgesic  delivery  systems  have  been 
employed to avoid under treatment of pain in children.  Many children will withdraw or 
deny their pain in an attempt to avoid yet another terrifying and painful experience, of 
the  intramuscular  injection.  Genitourinary  surgery  is  generally  associated  with 
considerable pain of long duration.
Caudal  extradural  block with bupivacaine ensures satisfactory analgesia  in the 
initial  postoperative  period  only.   It  becomes  ineffective  once  the  block  wears  off. 
Various methods have been devised to extend the duration of regional analgesia with 
local  anesthetics  like the placement of  a catheter  and using adjuvants like tramadol, 
ketamine,  neostigmine  and  opioids.   The  placement  of  catheter  carries  the  risk  of 
infection and delayed mobilization.
The use of ketamine, opioids and neostigmine is limited because of potential side 
effects like sedation, respiratory depression, nausea and vomiting.
The role of clonidine as an analgesic administered by extradural route is now well 
established in children.  Coadministration of caudal clonidine in a  dosage of 1μg|kg 
with  0.25% bupivacaine  has  been  found  to  prolong analgesia   without  any  adverse 
effects. 
Extradural  clonidine  in  a  dose  of  1  –  3μg|kg  added  with  local  anaesthetics 
intensifies  the analgesia  by approximately 50%.  The sedative property of  clonidine 
reduces the requirements of hypnotics and is often a desirable feature.
This study was conducted to assess the efficacy and safety of clonidine in low 
doses as an adjunct to bupivacaine for postoperative pain relief in paediatric patients.
LET US REMEMBER THE HIPPOCRATES OATH “DIVINE IS THE TASK 
TO RELIEVE PAIN”
II. AIM OF THE STUDY
To assess the efficacy of 1μ|kg of clonidine as a caudal adjunct to bupivacaine for 
postoperative pain relief in paediatric patients.
To assess the safety of clonidine, as a caudal adjunct to bupivacaine to increase 
the duration of analgesia.
III. ANATOMY OF THE CAUDAL EPIDURAL SPACE
SACRAL HIATUS
It is a bony defect, triangular in shape and situated at the lower end of the sacrum 
just  above the sacrococcygeal junction. The hiatus results from non-fusion of the 5th 
sacral and at times 4th sacral vertebral arches. It appears as an inverted U or V; the large 
bony processes on each side are called the cornua. The sacral cornua are in fact the 
embryological remains of the inferior articular processes of the 5th sacral vertebrae. The 
hiatus is covered by the sacrococcygeal membrane formed by the superficial and deep 
fibers of sacrococcygeal ligaments and is attached laterally to sacral cornua.
The sacrococcygeal membrane is actually a continuation of ligamentum flavum. 
The sacrum is cartilaginous in neonates and infants, and its ossification is completed 
between 25 to 30 years of age. At increasing age, the sacrococcygeal angle increases, 
thus closing sacral hiatus and therefore making caudal anaesthetic more difficult. This is 
especially true after the age of 7 years.
SACRAL CANAL AND THE CAUDAL EPIDURAL SPACE
The  sacral  canal  is  a  caudal  extension  of  the  spinal  canal.  The  spinal  canal 
contains the last spinal nerve roots, which forms the cauda equina and also the filum 
terminale that anchors spinal cord to coccyx and sacrococcygeal ligament. The dural sac 
projects upto S3 - S4 level at birth, reaching the adult level of S2 during second year of 
life.
The caudal epidural space in a neonate is filled with epidural fat, which has a 
gelatinous spongy appearance with distinct spaces between the fat globules and very few 
connective tissue fibers. This facilitates uniform and rapid spread of the local anaesthetic 
solutions. Between 6 to 7 years of age, the epidural fat gets denser and is surrounded by 
fibrous strands, thus reducing uniform spread of local anaesthetic solutions. The epidural 
space  is  richly  vascularised  and  the  veins  are  without  valves;  thus  an  inadvertent 
intravascular   injection can lead to instantaneous systemic toxicity.
  
Caudal anaesthesia requires identification of the sacral hiatus. The sacrococcygeal 
ligament overlying the sacral hiatus lies between the sacral cornu. To facilitate locating 
the cornu,  the posterior  superior  iliac spine should be located and by using the line 
between  them  as  one  side  of  an  equilateral  triangle,  the  location  of  sacral  hiatus 
approximated. After the sacral hiatus is identified the index and middle finger of the 
palpating hand are placed on the sacral cornu, and the caudal needle is inserted at an 
angle of approximately 45 degree to the skin in relation to the coccyx. While advancing 
the needle,  a  decrease in resistance to needle  insertion should be appreciated as  the 
needle enters the caudal space. The needle is advanced until bone is contacted and then 
slightly withdrawn, and the needle is redirected rostrally at a 20 to 30 degree angle to the 
skin. During redirection of the needle and after a loss of resistance is encountered again, 
the needle is advanced approximately 2 to 3 mm into the caudal canal.
Intravascular  or  intraosseous  injection:-This  may  lead  to  grand  mal  seizure  and 
cardio respiratory arrest.
Dural puncture: Extreme care must be taken to avoid this as a total spinal block will 
occur if a dose for a caudal block is injected into the subarachnoid space.
Perforation  of  the  rectum: While  simple  needle  puncture  is  not  important, 
contamination of the needle is extremely dangerous if it is then inserted into the epidural 
space.
Sepsis: This should be very rare occurrence if strict aseptic procedures are followed
Urinary  retention:  This  is  not  uncommon  and  temporary  catheterization  may  be 
required
Subcutaneous injection: This should be obvious as the drug is injected
Hematoma:
Absent or patchy block:
IV. PHARMACOLOGY OF BUPIVACAINE
The pharmacology of local anaesthetics is generally the same in children as it is in adults. There are differences like
1. Increased volume of distribution
2. Decreased protein binding of local anaesthetics
3. Enzyme immaturity
Decreased protein binding of local anaesthetics and enzyme immaturity can lead to 
systemic toxicity of local anaesthetics with high protein affinity.
Caudal injections of bupivacaine are now routinely used in children undergoing lower 
abdominal and urogenital surgery to provide intraoperative and postoperative analgesia. 
BUPIVACAINE
CH3
C4H9
  O
     N
NHC
CH3
It is an amide local anaesthetic characterized as pipecoloxylidides. Addition of a 
butyl group to the piperidine nitrogen of mepivacaine results in Bupivacaine. It is 
a chiral drug because of possession of asymmetric carbon atom.
It was first synthesized in Sweden by EKENSTAM and his colleagues in 1957 and used 
clinically by L.J.TELIVUO in 1963. Its molecular weight is 288.
MECHANISM OF ACTION 
It prevents transmission of nerve impulses by inhibiting passage of sodium ions 
through ion selective sodium channels in nerve membranes. They do not alter the resting 
transmembrane potential or threshold potential.
PHARMACOKINETICS
 It is a weak base that has pk value above physiologic pH.  At pH 7.4 only 15% exists in nonionised form. Absorption depends on the site of 
injection, dosage and use of epinephrine. Lung is capable of extracting bupivacaine from circulation, which will limit concentration of drug that reaches 
systemic circulation. This first pass pulmonary extraction is dose dependent suggesting that it becomes saturated rapidly.
 pk                                                       :          8.1
Protein Binding                                   :          95%
Lipid solubility                                    :          28
Volume of distribution                       :          73 litre
Clearance of drug from plasma          :          0.471 lit/min
Elimination half life                           :          210 min   (3.5 hours)
Onset time                          : 5 -7 min
t ½ α                            :          2.7 min
t ½ β                           :          28 min
METABOLISM 
 Slowest  metabolism  among  amide  local  anaesthetics.  It  undergoes  aromatic 
hydroxylation, N- dealkylation, amide hydrolysis and conjugation. Only the N-desbutyl 
bupivacaine has been measured in blood or urine after epidural or spinal anaesthesia. 
Alpha-1 acid glycoprotein is the most important protein-binding site of bupivacaine.
SIDE EFFECTS
Bupivacaine is more cardio toxic than equieffective doses of   Lignocaine. This is 
manifested by severe ventricular arrhythmias and myocardial depression. Bupivacaine 
blocks cardiac Na+ channels rapidly during systole and dissociates more slowly during 
diastole, so that a significant fraction of Na+ channels remain blocked at the end of the 
diastole. Thus the block by Bupivacaine is cumulative and substantially greater.
CLINICAL USE
Onset of anaesthesia and duration of action are long. Its tendency to provide more 
sensory than motor block has made it  popular for providing postoperative analgesia. 
Used for
o Infiltration anaesthesia   
o Field block anaesthesia
o Nerve block anaesthesia
o Spinal anaesthesia
o Epidural anaesthesia
RECOMMENDED DOSE
   Bupivacaine without epinephrine     – 2 mg/Kg
   Bupivacaine with epinephrine          – 3 mg/Kg
TOXIC PLASMA CONCENTRATION THRESHOLD
- 2 µg / ml
V. PHARMACOLOGY OF CLONIDINE HYDROCHLORIDE
H                           Cl
| N    . HCl
N
NH           Cl
N – (2,6 – dichlorophenyl) -4, 5 –dihydro – 1H – imidazol – z – amine.
Clonidine  is  a  direct  acting  ά2 agonist  prescribed  historically  as  an 
antihypertensive  agent.   In  addition  to  its  antihypertensive  effect,  in  recent  studies, 
clonidine has been demonstrated to be an effective sedative and analgesic and to reduce 
the amount of anaesthetic agents required.   Therefore, a reconsideration of possible new 
indications for clonidine in clinical anesthesiology seems to be justified.
MECHANISM OF ACTION
Clonidine is a selective partial ά2 – adrenergic agonist with a selectivity ratio of 
about 200: 1 in favour of ά2 receptors.   It is lipid soluble and easily penetrates the blood 
brain  barrier  to  reach  the  hypothalamus  and  medulla  when  injected  epidurally.   It 
stimulates the inhibitory ά2  – adrenergic receptors located on neurons in the superficial 
laminae of spinal cord and brainstem nuclei thereby reducing central neural transmission 
of pain impulses.  Inhibition of substance – p release is believed to be involved in the 
analgesic effect.  
Some contribution to the analgesic effect of clonidine may be through release of 
acetylcholine in the neuraxial region.  This enhances sensory and motor block of C and 
A ά fibres by local anaesthetics by increasing potassium conductance.
Sedation usually accompanies the use of clonidine through its actions on the locus 
ceruleus.   Sedation  after  epidural  clonidine  likely  reflects  systemic  absorption  and 
vascular redistribution to higher centers.
Clonidine affects blood pressure in a complex fashion after neuraxial or systemic 
administration because  of  opposing actions at  multiple  sites.   In  the  nucleus  tractus 
solitarius and locus ceruleus of the brainstem, activation of postsynaptic ά2 – adrenergic 
receptors  reduces  sympathetic  drive.   It  also  activates  non-adrenergic  imidazoline  – 
preferring binding sites in the lateral reticular nucleus, thereby producing hypotension 
and  an  anti-arrthymic  action.   In  the  periphery,  its  action  on  presynaptic  ά2  – 
adrenoceptors  at  sympathetic  terminals  reduce  the  release  of  norepinephrine  causing 
vasorelaxation and reduced chronotropic drive.  The brainstem and peripheral effects of 
ά2  - adrenoceptor stimulation are counterbalanced by direct peripheral vasoconstriction 
through its action on  ά1-  adrenoceptors from circulating concentrations of clonidine. 
As a result, the dose – response for clonidine by neuraxial or systemic administration is 
U-shaped, with peripheral vasoconstriction from circulating drug concentrations at high 
doses opposing central sympatholysis.
PHARMACOKINETICS 
Clonidine  is  highly  lipid  soluble  and  hence  rapidly  absorbed  after  oral, 
intravenous  and  epidural  administration.   After  epidural  administration,  clonidine  is 
rapidly and extensively absorbed into the spinal CSF compartment, with concentration 
peaking 30 to 60 minutes after injection.  There is a strong correlation between clonidine 
concentration  in  the  CSF  and  analgesia  after  epidural  clonidine  administration. 
Epidurally administered clonidine readily partitions into plasma via the epidural veins 
and  attains  systemic  concentrations  (0.5  –  2  ng  |  ml)  that  are  associated  with  a 
hypotensive  effect  mediated  by  the  central  nervous  system.   After  intravenous 
administration  it  is  readily  distributed  into  extravascular  sites  including  the  central 
nervous system.
Molecular mass 230.093 gm / ml
Bioavailability 75 – 95%
Protein binding 20 – 40%
Volume of distribution 2.1 + 0.4 L / Kg
Elimination T ½ 9 + 2 hrs
Onset time 26 + 11 mins
METABOLISM
In  the  liver  it  undergoes  hydroxylation  to  form  major  metabolite  p-
hydroxyclonidine. Only 50% of the drug is metabolized in the liver and the remaining is 
excreted as unchanged drug in the urine.  Plasma albumin is the most important protein 
binding site for clonidine varies between 20 – 40% in vitro.
SIDE EFFECTS
The most common side effects produced by clonidine are drowsiness, drymouth, 
bradycardia and hypotension.  It also causes inhibition of orgasm in women.  Rebound 
hypertension can occur after abrupt discontinuation of clonidine therapy (1.2 mg / day) 
as early as 8 hours and as late as 36 hours after the last dose.  Rebound hypertension can 
usually  be  controlled  by  reinstituting  clonidine  therapy  or  by   administering  a 
vasodilating drug such as hydralazine or  sodium nitroprusside. 
CLINICAL USE
HYPERTENSION
Clonidine has been proved to be effective in treatment of patients with severe 
hypertension or renin dependent disease.  The usual daily adult dose is 0.2 to 0.3 mg 
orally.  Transdermal  clonidine patch designed for  weekly administration is  useful  for 
surgical patients who are unable to take oral medications.
ANALGESIA
Preservative free clonidine administered into the epidural or subarachnoid space 
produces  dose  dependent  analgesia  and unlike opioids,  does not  produce respiratory 
depression, pruritus,  delayed gastric emptying, nausea and vomiting.  It prolongs the 
effects of  both sensory and motor blockade. 
PREANESTHETIC MEDICATION
Oral preanesthetic medication (3 to 5μg/kg) dose of clonidine (a) blunts reflex 
tachycardia associated with direct laryngoscopy for intubation of trachea (b) decreases 
intraoperative  lability  of  blood  pressure  and  heart  rate.   (c)  decreases  plasma 
catecholamine  concentrations  (d)  dramatically  decreases  anaesthetic  requirements  for 
inhaled and injected drugs.
TREATMENT OF SHIVERING
Slow intravenous administration of clonidine 30μg stops shivering 
ATTENUATION OF HEMODYNAMIC EFFECTS OF KETAMINE
Oral clonidine premedication 5 μg|kg administered 90 minutes before induction of 
anesthesia attenuates the blood pressure and heart rate increases that normally follow the 
administration of ketamine 1 mg | kg intravenously.
TREATMENT OF OPIOID WITHDRAWAL
Clonidine is effective in suppressing the signs and symptoms of withdrawal from 
opioids. Clonidine may be useful in attenuating the symptoms associated with cigarette 
smoking and nicotine withdrawal.
DOSAGE GUIDELINES: CLONIDINE DOSE
Intrathecal - 15 μg to 30 μg
Epidural - 1 μg | kg (or) 50 μg
30 μg | hr (for infusion)
Intravenous - 50 – 75 μg (or) 1μg | kg    15 minutes prior to       
induction for intubation response attenuation
150 – 300 μg (or) 3 μg / kg for hypertensive crisis
30 μg given slowly for shivering management.
VI. CALCULATION OF THE VOLUME OF LOCAL 
ANAESTHETIC FOR CAUDAL ANAESTHESIA
Many formulae based on weight, age and number of spinal segments to be blocked and the parameter  ’D’ (Distance from C7 to sacral Hiatus) have been 
used to determine the dose of local anaesthetic required.
SPIEGEL et al (6) described a formula to calculate the total volume of Bupivacaine (V) 
depending on the distance separating the sacral hiatus from the spinous process of the 7th 
cervical vertebra as follows 
                    V = 4 + (D-15)/2 
   V-Volume of local anaesthetic 
  D- Distance from C7 to sacral Hiatus
BROMAGE  PR  et  al  (23)  proposed  a  formula  to  determine  the  volume  of  local 
anaesthetics to be injected into the caudal epidural space depending on the age of the 
patient and per spinal segment.
V = 0.106 + (0.075 X Age in years)
V-Volume of local anaesthestic per spinal segment
TAKASAKI M  et  al  (24) suggested  a  calculation  depending  on the  weight  of  the 
patient in kg.
V = 0.056 ml X Body weight (in kg) X number of spinal segments to be blocked.
SCHULTE  –  STEINBERG  examined  the  statistical  influence  of  age,  weight  and 
height on caudal dose requirements before puberty. He found that the pattern of spread 
was highly predictable in children. The relationship between age and dose requirements 
was strictly linear = 0.1 ml / segment / year of age.
V is volume in ml of 1% lignocaine or 0.25% bupivacaine.
In practice, however, it is easier to use the formula describes by ARMITAGE EN et al 
(5)
LUMBOSACRAL                        0.5 ml/kg
THORACOLUMBAR                  1 ml/Kg
MIDTHORACIC                          1.25 ml/Kg
Of 0.25% bupivacaine.
MODIFIED ARMITAGE EN et al
Sacral 0.5 ml / kg
Thoracic (T10) 0.75 ml / Kg
Thoracic (T6) 1 ml / Kg
Mid Thoracic (T4) 1.25 ml / Kg  
Of 0.25% bupivacaine.                                 
Modified Armitage formula was used in this study. This formula is easy to use, 
reliable and safe in children.
VII. ASSESSMENT OF PAIN IN CHILDREN
Children present problems of assessment of pain when compared with adults because 
of their lower level of verbal fluency and the likelihood that varying development levels 
alter their understanding of questions or tests. Hence assessment of pain proved difficult 
in  children.  Assessment  and  management  are  interrelated.  Unfortunately  validated 
totally  acceptable  tools  for  measuring  pain  in  children  are  not  available.  Various 
methods are available as per Brown TCK. (25)
1. Physiological measurements
2. Self report techniques
3. Behavioural  assessment
PHYSIOLOGICAL MEASUREMENTS
Changes  in  pulse,  blood  pressure  and  respiration  reflect  autonomic  arousal. 
Autonomic responses to pain and their measurement form an important aspect of certain 
pain  scales.  Metabolic  changes  cause  release  of  catecholamine,  growth  hormone, 
glucagons, cortisol, aldosterone and beta-endorphins, which have been documented in 
infants  and  children  following  noxious  stimulation.  Only  plasma  cortisol  has  been 
shown to correlate with behavioural responses to noxious stimuli.
SELF REPORT TECHNIQUES 
As described by  Manuksela et al, (6) these are the best indicators of a child’s 
subjective experience. Various methods have been used:
(a) VISUAL ANALOGUE SCALE  (26)
 The accepted method of measurement of pain in adults is acceptable and provides 
reproducible results in children down to an age of five years. VAS using a 10 cm length 
scale marked “no pain” at one to “worst pain possible” at the other end. The child is 
asked to  identify  a  point  on  the  scale,  which  corresponds  to  his  pain.  The  point  is 
measured from the left hand end and reported in mm from 0 to 100 or in cm from 0 to 
10. A score of less than 4 is no pain, less than 6 implies tolerable pain and more than 6 
means he needs medication. 
(b) OUCHER SCALE  (7)
It  is  a  variant  of  the faces scale  and is  designed to  measure pain intensity  in 
children aged 3 to 12 years. The scale is displayed in a poster format. It consists of a 
vertical numerical scale (0 to 100) on the left and six photographs of children in varying 
degrees  of  pain  positioned  vertically  to  the  right.  This  scale  is  based  on  mimic, 
vocalization and irritability. 
Characteristics of increasing pain are:
(1)Distortion of face such as lowering of the brow, broadening of the nasal root, 
angular and squarish mouth, tightly closed eyes and tightening of the jaw.
(2) Vocalization,  changing  from  sobbing  or  groaning  to  cry.                 
(C) WONG – BAKER FACES PAIN RATING SCALE (8)
It is recommended for persons of age three and more. It contains six different 
faces of expression varying from a happy to sad mood. The patient has to be explained 
that each face is for a person who feels happy because he has no pain (hurt) or sad 
because  he  has  some or  a  lot  of  pain.  Ask the patient  to  choose  the face  that  best 
describes how he is feeling.  
A  similar  scale  was  designed  by  Daiva  Bieri et  al  (9) to  assess  pain  in  the 
Children’s  Hospital,  University  of  Helsinki.  This  scale  was  based  on  mimic, 
vocalization, movements or rigidity of the limbs and the body, response to handling and 
irritability together with the measured cardioventilatory parameters. 
BEHAVIOURAL ASSESSMENT
This method of assessment relies on observation of behaviour and is more useful 
in the pre-school age group of children. They score the behaviour, which represent the 
reaction  to  pain  and  scores  are  allotted  according  to  the  degree  of  alteration  of  a 
particular behaviour .The behavioural score include vocal behaviour such as cry, scream, 
verbally expressed pain and anxiety and nonverbal behaviour such as muscle rigidity, 
torso movements, leg movements, facial expression.
(1) THE PBRS: Pain  behaviours  rating  scale  and Children’s  Hospital  of  Eastern 
Ontario pain scale -  CHEOPS (10)  are the two such scales. The observation in 
these scales can have an observer bias.
(2)THE  OBJECTIVE  PAIN  SCALE: This  measures  pain  as  a  physiological 
variable, blood pressure along with behavioral changes. This has been shown to be a 
sensitive and reliable tool in evaluating postoperative pain in children who are not 
able to verbally comment upon their pain experience. This takes into account the 
systolic blood pressure, cry and it’s response to love and care, movement, agitation 
and verbal evaluation as described by Hannallah RS. (28)
Children’s Hospital Eastern Ontario Pain Scale (CHEOPS)
(Recommended for children 1-7 years old) – A score greater than 4 indicates pain.
Item Behavioral Definition Scor
e
Cry No cry
Moaning
Crying
Scream
1
2
2
3
Child is not crying
Child  is  moaning  or  quietly  vocalizing 
silent cry.
Child  is  crying,  but  the  cry  is  gentle  or 
whimpering
Child is in a full-lunged cry, sobbing; may 
be  scored  with  complaint  or  without 
complaint.
Facia
l
Composed
Grimace
Smiling
1
2
0
Neutral facial expression.
Score  only  if  definite  negative  facial 
expression.
Score  only  if  definite  positive  facial 
expression.
Child 
verba
l
None
Other complaints
Pain complaints
Both Complaints
Positive
1
1
2
2
0
Child not talking.
Child complains, but not about pain, e.g., 
“I want to see mommy” of “I am thirsty”.
Child complains about pain.
Child  complains  about  pain  and  about 
other  things,  eg.,  “It  hurts;  I  want  my 
mommy”.
Child  makes  any  positive  statement  or 
talks  about  others  things  without 
complaint.
Tors
o
Neutral
Shifting
Tense
Shivering
Upright
Restrained
1
2
2
2
2
2
Body  (not  limbs)  is  at  rest;  torso  is 
inactive.
Body  is  in  motion  in  a  shifting  or 
serpentine fashion.
Body is arched or rigid.
Body  is  shuddering  or  shaking 
involuntarily.
Child is in a vertical or upright position.
Body is restrained.`
Touc
h
Not touching
Reach
Touch
Grab
Restrained
1
2
2
2
2
Child  is  not  touching  or  grabbing  at 
wound.
Child  is  reaching  for  but  not  touching 
wound.
Child is gently touching wound or wound 
area.
Child is grabbing vigorously at wound.
Child’s arms are restrained.
Legs Neutral
Squirm/Kicking
Drawn up / tensed
Standing
Restrained
1
2
2
2
2
Legs  may  be  in  any  position  but  are 
relaxed;  includes  gentle  swimming  or 
separate – like movements
Definitive  uneasy or  restless  movements 
in the legs and/or striking out with foot or 
feet.
Legs  tensed  and/or  pulled  up  tightly  to 
body and kept there.
Standing, crouching or kneeling.
Child’s legs are being held down.
FLACC Scale
Category
Scoring
1
2
3
Face
No particular 
expression or 
smile
Occasional 
grimace or 
frown, 
withdrawn, 
disinterested
Frequent to 
constant 
quivering chin, 
clenched jaw
Legs
Normal 
position or 
relaxed
Uneasy, 
restless, tense
Kicking, or legs 
drawn up
Each of the five categories (F) Face; (L) Legs; (A) Activity; (C) Cry; (C) Consolability 
is scored from 0-2, which results in a total score between zero and ten.
TABLE -1: OBJECTIVE PAIN SCALE
TLC -   TOUCH, LOVE AND CARE
VIII. MATERIALS AND METHODS
The study population consisted of 40 ASA I and ASA II children in the age group 
of 2 years to 8 years admitted to undergo elective lower abdominal  general  surgical 
procedures at our hospital.
Exclusion  criteria  consisted  of  local  infection  in  the  caudal  region,  bleeding 
diathesis,  preexisting neurological (or) spinal diseases and congenital anomaly of the 
lower back.  The study was approved by the institutional ethics committee.
A written consent was obtained from the parents after they were informed about 
the procedure to be performed, to give post operative analgesia for their children.  The 
children  were  allocated  randomly  into  two groups  of  20  patients  each.   One group 
named group B received 0.75 ml/kg of 0.25% bupivacaine alone.  Another group named 
group BC received 0.75ml/kg of 0.25% bupivacaine with 1microgram/kg clonidine.
All  children  were  kept  fasting  for  6  hours.   They  were  received  by  an 
anaesthesiologist  inside  the  premedication  room  one  hour  before  surgery. 
Preanaesthesia  check  up  was  done  and  the  children  were  premedicated  with  syrup 
midazolam  0.5 mg/kg 45 minutes prior to the surgery.
After  premedication,  they  were  received  by  an  anaesthesiologist  inside  the 
operation room for surgery.  Baseline cardio respiratory parameters such as pulse rate, 
noninvasive  blood  pressure,  electrocardiogram,  respiratory  rate  and  oxygen 
saturation(SpO2
)  were  recorded  and  monitored  continuously  every  5  minutes 
intraoperatively and thereafter every 30 minutes for next 12 hrs.
Patients were induced with increasing concentration of halothane (0.4-2%) with 
oxygen  30%  and  nitrous  oxide  70%  mixture  using   T  –  piece  with  Jackson  Rees 
modification  and  facemask.   Intravenous  line  was  secured  after  achieving  adequate 
depth of anaesthesia.
Intubation is facilitated with Inj.suxamethonium chloride 2mg/kg.    Patients were 
intubated with an appropriate size uncuffed endotracheal tube orally.  No opioids were 
used intraoperatively. 
Under  controlled  ventilation,  muscle  relaxation  was  maintained  with 
Inj.vecuronium 0.08mg/kg.  Anaesthesia was maintained with halothane 0.5 – 1% and 
70 % nitrous oxide in oxygen mixture.
After  induction  of  anaesthesia,  the  patients  were  positioned  in  the  left  lateral 
position with hips and knees flexed.
Under strict aseptic precautions, a 22 G hypodermic needle was inserted in the 
sacral hiatus at 45 degree angle to the skin.  Once the sacrococcygeal membrane was 
penetrated  and loss  of  resistance  obtained,  the  angle  was  changed and  needle  was 
directed  up  the  canal  for  further  2  to  3  mm.   The  injection  was  made  after  gentle 
aspiration  to  rule  out  any  intrathecal  or  intravascular  placement.  Group  B  received 
0.25% bupivacaine alone. Another group BC received 0.25% bupivacaine with clonidine 
1microgram/kg.
The dosage  of  local  anaesthetic  injected  into  the  caudal  space  was  calculated 
according to the MODIFIED ARMITAGE formula.
The surgical incision was made 10 minutes after administering the caudal block. 
Meanwhile the children were surgically prepared and draped.  
Adequate caudal analgesia was defined as haemodynamic stability as indicated by 
absence of increase in heartrate and mean arterial pressure of more than 15% compared 
with baseline values obtained just before surgical incision. 
If  the  mean  arterial  pressure  increased  by  more  than  15% of  baseline  value, 
analgesia  was  considered  inadequate  and  rescue  opioids  like  Inj.Fentanyl  2 
microgram/kg was given.  These patients were excluded from the study.
Intraoperative  fluid  management  was  taken  care  by  using  HOLIDAY  AND 
SEGAR formula.
On completion of surgery, the residual effect of the muscle relaxant was 
reversed with Inj.neostigmine 50 microgram/kg and Inj.atropine 20 microgram/kg and 
patients were extubated when fully awake.
The  recovery  was  assessed  using  MODIFIED  ALDRETE  SCORE (27)  and 
children were shifted to the post operative ward, where monitoring of respiratory rate, 
oxygen saturation (SpO2
),  pulse rate and blood pressure were continued.  The quality of 
analgesia was assessed hourly, for the first 6 hours and then every 2 hours for the next 6 
hours.
The  intensity  of  pain  was  measured  using  the  OBJECTIVE  PAIN  SCALE 
SCORE devised by  HANNALLAH RS.(28).   Each parameter was awarded a score of 
0-2 accordingly.  The sum total of the awarded score was taken at each time interval.  A 
log  was  kept  at  the  bedside  for  noting  the  occurrence  of  possible  complications 
including hypotension, bradycardia and respiratory depression.
Patients were administered rescue analgesia with Syrup paracetamol 10mg/kg on 
evidence of pain (i.e) if the  OBJECTIVE PAIN SCALE reached a value of 5.  The 
duration  of  analgesia  was  calculated  from the  time  of  injection  of  the  drug  in  the 
epidural space to the time when OPS reached 5.
Postoperative sedation score was done using  RAMSAY SCALE every one hour 
for first 6 hours and then every 2 hours for the next 6 hours.  Respiratory depression was 
defined as decrease of (SpO2
)  less than 93% or a decrease in respiratory rate less than 
10/min.  Excessive sedation was defined as a RAMSAY SEDATION SCORE of V or 
VI
Caudal block and monitoring of scores for pain and sedation were performed by 
anaesthesiologists blinded to the study allocations.
TABLE –II     MODIFIED ALDRETE’S SCORE
TABLE III: RAMSAY SEDATION SCORE
Six point sedation score was assigned as follows
SCORE CLINICAL DESCRIPTION
I          Anxious, Agitated 
II
     
Cooperative, Oriented, Tranquil
III
       
Responds only to verbal commands
IV
      
Asleep with brisk response to light stimulation
V
    
Asleep with sluggish response to stimulation
VI
     
Asleep without response to stimulation
IX. OBSERVATION AND ANALYSIS
Forty  Patients posted for elective  lower  abdominal  general surgical  procedures 
who were admitted in  the Department  of  Paediatric surgery,  RAJA MIRASUDHAR 
HOSPITAL,  THANJAVUR MEDICAL COLLEGE,  of  Physical  status  ASAI  and II 
were taken up  for  the study. 
They were randomly divided into two groups of 20 patients each to receive caudal 
block as mentioned below.
One group (group BC) received a mixture of 0.75ml / kg of 0.25%  bupivacaine 
and  1microgram/kg clonidine, 20 minutes  before surgery.   Other group (group B) 
received 0.75ml  /  kg  of  0.25% .bupivacaine  alone  20  minutes  before  surgery.   The 
patients were assessed by a blinded observer in the postoperative period.
AGE AND SEX DISTRIBUTION
The age distribution in both groups ranged from 2-8 years as follows.
AGE IN 
YEARS
GROUP B GROUP  BC
MALE FEMALE MALE FEMALE
2 – 4 6 3 6 2
5 – 6 5 3 4 2
7 2 1 4 2
13 7 14 6
From this table it is clear that the number of children in 2 – 4 yrs,     5 – 6 yrs and 
7 years  interval are not much different between the two groups.  This shows  age was 
not a confounding  factor. 
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In this bar diagram, the horizontal axis represents age in years and vertical axis 
represents the number of patients.  The age distributions in both groups are not much 
different.
Mean Age in years + 
S.D
GROUP B GROUP BC P VALUE
4.8 + 1.44 5.15 + 1.63 0.48
S.D (Standard deviation)
There was no statistically significant  difference in age distribution (P > 0.05). 
Hence there is no bias in the age distribution. 
                                       DISTRIBUTION
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In group B 65% are male and 35% are female and in group BC 70% are male and 
30% are female.   The sex distribution in both the group is also not much different. 
Hence there is no bias in the sex distribution.
WEIGHT DISTRIBUTION
Mean Wt in kgs  + S.D
GROUP B GROUP BC P VALUE
22.1 + 5.18 18 + 5.41 0.46
S.D (Standard deviation)
There was no statistically significant difference in weight distribution (P > 0.05). 
Hence there is no bias in the weight distribution. 
TYPES OF SURGICAL PROCEDURES
The various surgical procedures performed are shown below.
SURGICAL 
PROCEDURES GROUP B GROUP BC
Herniotomy 12 12
Pvsac ligation 5 4
Hypospadias 3 4
Total 20 20
From this table it is clear that the type of surgical procedures between the two 
groups is not much different.  Hence there is no bias in the type of  surgical procedures.
DURATION OF ANALGESIA
Duration of analgesia in group B  (0.25% Bupivacaine)  ranged from 3 to 5 hours 
with  a  mean   duration  of  4.3  hours.  Duration  of  analgesia  in  group  BC  (0.25% 
Bupivacaine and 1microgram/kg clonidine)  ranged from 9 to  12 hours with a  mean 
duration of 10.2 hours.
DURATION OF ANALGESIA
Mean duration of 
Analgesia in hrs  + S.D
GROUP B GROUP BC P VALUE
4.3 + 0.73 10.2 + 1.01 0.0001
S.D (Standard deviation)
DURATION OF ANALGESIA
The mean duration of analgesia in group BC is 10.2 hours, whereas in group B it 
is  only about 4.3 hours.     This means that  group BC has got  extended duration of 
analgesia when compared with group B.  This duration of analgesia is also statistically 
significant as detected by using student ‘T’  test,  by which the probability  value is  less 
than 0.05 (P < 0.0001).  This P value means that it is highly significant.  
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MEAN HAEMODYNAMIC CHANGES
In both the groups there was no  significant  change in the heartrate  from the base 
line value,   both in  the intraoperative  and in the postoperative  period (P > 0.05). 
Changes  in the  MAP  (Mean  arterial pressure)  in the both groups   did not show any 
marked   deviation  from the  base line (P > 0.05).
Mean Haemodynamic changes
Group  B
Mean heart 
rate  / min
Group BC
Mean heart 
rate / min
P value
Preoperative 112 + 8 110 + 8 0.42
During Intubation 123 + 9 122 + 8 0.63
Intra operative 108 + 6 108 + 10 0.88
Post operative 98 + 5 102 + 8 0.074
Mean Haemodynamic changes
Group  B
Mean  arterial 
pressure
(mm Hg)
Group BC
Mean arterial 
pressure
 (mm Hg)
P value
Preoperative 84 + 3 83 + 5 0.55
During Intubation 96 + 4 95 + 4 0.85
Intra operative 84 + 4 84 + 3 0.58
Post operative 77 + 5 79 + 2 0.067
SEDATION
Post operative sedation score was done using RAMSAY SCALE every one hour 
for first 6 hours  and then every 2 hours for next 12 hours.  At no time during the study 
period  were the patients  deeply sedated requiring Oxygen  supplementation.  Patients 
had a sedation score of  III,  IV as per Ramsay scale in the post operative period.  Group 
BC had more number of patient with a sedation score of  III and IV,as per RAMSAY 
scale, when compared to group B. In both the groups no patient had a sedation score of 
V or VI.
RAMSAY  SEDATION SCORE
GROUP B GROUP BC
Number of patients
I Nil Nil
II 12 2
III 6 10
IV 2 8
V Nil Nil
VI Nil Nil
X. REVIEW OF LITERATURE
Caudal block is a simple and safe technique, which can be routinely adopted in 
children.  This provides effective intraoperative and postoperative analgesia for almost 
all  types  of  interventions  on  the  lower  part  of  the  abdomen  and  the  lowerlimbs, 
especially in neonates, infants and certain high risk children as per the experience of 
ARMITAGE EN (11) AND ARTHUR DS (12)
Caudal  anaesthesia  is  usually  but  not  always  combined  with  a  light  general 
anaesthesia  with  Halothane  followed  by  Isoflurane  either  at  the  beginning  or, 
sometimes, at the end of surgical procedure.  DALENS B, HASNAOUTA (13)
HANNALLAH RS (15) et al conducted a study in children in the age group of 18 
months to 12 years scheduled for orchidopexy to evaluate the effectiveness of caudal 
analgesia and compared it with local nerve blocks.  They found that both caudal as well 
as Ilioinguinal/Iliohypogastric nerve blocks administered following inhaled anaesthesia 
for  orchidopexy  are  safe  and equally  effective  in  controlling  post  operative  pain  of 
children.
GUNTER (16)   et  al  conducted  a  study  on  122  children  aged  1  to  8  years 
scheduled for out patient inguinal herniorhaphy who were randomized to receive, in a 
double  blind  fashion,  caudal  anaesthesia  with  bupivacaine  in  one  of  the  six 
concentrations (0.125%, 0.15%, 0.175%, 0.2% 0.25% and  0.5%).  
After incision a programmed reduction in inspired halothane resulted, if tolerated 
by the subject.   Although all concentrations were effective for combined general caudal 
anaesthesia  in  children,  they  concluded  that  0.175%  bupivacaine  offers  the  best 
combination  of  effectiveness,  rapid  recovery  and  discharge  for  paediatric  surgical 
outpatients without any motor blockade.
In another study by  WOLF AR(17) et al on 114 infants and children of age 6 
months to 10 years, undergoing elective superficial lower abdominal or genital surgery 
to find the optimum concentration of bupivacaine for caudal analgesia, concluded that 
0.125% bupivacaine with 1 in 2,00,000 adrenaline provided equipotent analgesia and 
significantly less motor blockade than 0.25% bupivacaine.
LEE (18) et al conducted a randomized double blind study in children underging 
elective orthopaedic surgery and assessed the clinical value of combining clonidine with 
bupivacaine for caudal analgesia.  Forty six children aged 1 – 10 years were randomly 
allocated  into  two  groups  to  receive  0.25%  bupivacaine  1  ml/kg  alone  and  0.25% 
bupivacaine  –  clonidine  2microgram/kg  mixture.   Bupivacaine  –  Clonidine  mixture 
group  required  significantly  less  supplementary  analgesia  postoperatively.   He 
concluded that the addition of clonidine 2microgram/kg to 0.25% bupivaccaine 1ml/kg 
significantly prolonged the duration of caudal analgesia(9.8 hours) compared with that 
provided by bupivaccaine alone (5.2 hours).
KLIMSCHA (20)  evaluated  the  analgesic  efficacy  and  haemodynamic  and 
respiratory  safety  of  clonidine  when  added  to  bupivacaine  for  caudal  blocks  in  58 
children aged 2 to 3 years coming for hernia repair.  Patients were randomly given a 
caudal injection of 0.75ml/kg of either saline placebo(P group), bupivacaine 0.25% (B 
group),   bupivacaine 0.25% plus epinephrine 1 in 2,00,000 (BE group),  bupivacaine 
0.25% plus clonidine 1 microgram/kg (BC 1 group) or bupivacaine 0.25% plus clonidine 
2 microgram/kg (BC 2 group).  The duration of analgesia was significantly longer in 
BC1 (6 Hours) and BC2 (6 hours).  Bradycardia and respiratory depression were not 
observed.  He concluded that clonidine 1 and 2microgram/kg can be safely added to 
bupivacaine caudal blockade in small children for ambulatory hernia repair to achieve an 
increased duration of analgesia.
DE KOCK  (21) investigated the analgesic potency of epidural clonidine when 
used as an sole analgesic agent during and after major abdominal surgery in 56 young 
adult  patients.   He  concluded  that  epidural  clonidine  produced  dose  dependent 
intraoperative and postoperative analgesia without major side effects.
EISANACH JC (22) et al conducted a randomized study in 280 patients of age 3 
to 6 years for infraumbilical surgery at epidural clonidine doses 1-5microgram/kg with 
0.125% bupivacaine 1 ml/kg.  He concluded that addition of 1-3 microgram/kg clonidine 
to 0.125% bupivacaine epidurally doubles duration of post operative analgesia compared 
with bupivacaine alone(6.2hours)  But in doses more than 3 microgram/kg clonidine 
there was haemodynamic depression.
JAMALI(19) et al conducted a randomized double – blind study in 45 paediatric 
patients aged 1 – 7 years presenting for subumbilical surgery and assessed the efficacy 
of clonidine as adjunct to bupivacaine for caudal analgesia.   Patients were randomly 
allocated  in  to  three  groups  of  15  each.   one  group  received  1  ml/kg  of  0.25% 
bupivacaine with epinephrine 1 in 2,00,000 (EG), another group received 1 ml/kg of 
0.25% bupivacaine  with  clonidine  1  microgram/kg (CG)  and last  group 1  ml/kg  of 
0.25% bupivacaine alone.  
The mean duration of analgesia was longer in the bupivacaine - clonidine mixture 
group (16hours).  He concluded that the duration of postoperative analgesia with caudal 
bupivacaine was significantly increased by addition of clonidine 1 microgram/kg.
XI. DISCUSSION
The past decade has witnessed many advances in the understanding and treatment 
of pain in children.  Recently regional blocks are being used for pain relief in children. 
Local anaesthetic agents have been routinely used for regional blocks in children. The 
use of adjuncts can effectively help in reduction of the dose and an increase in duration 
of the local anaesthetic agents.
This study was undertaken to assess the efficacy and safety of  clonidine with 
bupivacaine in paediatric patients undergoing lower abdominal surgeries under caudal 
analgesia.  KLIMSCHA.W et al carried out a similar study and concluded that clonidine 
1microgram/kg and 2microgram/kg can be safely added to bupivacaine caudal blockade 
in  small  children  for  ambulatory  hernia  repair  to  achieve  an  increased  duration  of 
analgesia  (median  [range])  was  (360  [270-360]  minutes  and  360  [355-360]  minutes 
respectively).  The major drawback of their study was the limited time of post operative 
assessment because of early discharge (6 hours.).   In our study, the duration of post 
operative  assessment  was  12hours  to  assess  the  maximum  duration  of  analgesia 
provided by clonidine and local anaesthetic combination.
In  a  study  by  JAMALI  .S et  al  on  the  advantage  of  the  use  of  clonidine  in 
paediatric  regional  analgesia,  the  dose  of  bupivacaine  used  was  1ml/kg  of  0.25% 
bupivacaine and duration of analgesia was 16 hours.  In the present study however, 0.75 
ml/kg of 0.25% bupivacaine was used.  The dose of clonidine used was 1microgram/kg 
and the duration of analgesia was 10.2 hours.  This may be explained by the fact that the 
quality, level and duration of the caudal blockade is depends on the dose, volume and 
concentration  of  the  injected  drugs  as  per  SILVANI,  CAMPORESI,  AGOSTNO, 
SALVO study (14). They compared the duration of post operative analgesia in children 
undergoing  hypospadiasis  repair  when  two  different  volumes  and  concentrations  of 
fixed  doses  of  ropivaccaine  were  used.  They  concluded  that  high  volume  low 
concentration regimen produces prolonged analgesia as compared to low volume high 
concentration regimen.
LEE .JJ et  al  in  their  study used  clonidine  in  the  doses  of  2microgram/kg in 
children undergoing orthopaedic surgery and found significant prolongation of analgesia 
(9.8 hours) as compared to bupivacaine (5.2 hours).  However, when compared to the 
present  study,  there  is  no  added  advantage  of  increasing  the  dose  of  clonidine  to 
2microgram/kg  from  1microgram/kg,  because  there  is  no  marked  increase  in  the 
duration of analgesia in the two studies.  In our study, the dose of clonidine used was 
1microgram/kg  with  0.75ml/kg  of  0.25%  bupivaccaine  in  children  undergoing 
superficial infraumblical surgeries and the duration of analgesia was 10.2 hours. This 
may be due to the different type of surgical procedures in both the studies.In the LEE JJ 
et al study,the patient have undergone orthopedic surgery which requires more analgesia 
when compared  to superficial infra umbilical surgeries done in our study.
EISENACH et al found hypotension and bradycardia as the most common side 
effect with caudal clonidine in a dose dependant manner, the incidence being  less with 
1microgram/kg.This study confirms the finding of haemodynamic changes as shown by 
other  workers.   There was no significant  decrease in heart  rate,  respiratory rate and 
blood pressure from the baseline with the use of clonidine in a dose of 1microgram/kg 
with bupivacaine in caudal epidural analgesia.
There  was  no  significant  sedation  in  the  post  operative  period  leading  to 
respiratory  depression.   The  sedation  score  was  either  IV or  less  as  per  RAMSAY 
SCALE in all patients.  KLIMSCHA et al have shown in their study that the sedation 
score  was  lower  in  the  group  who  were  administered  clonidine  1microgram/kg  as 
compared to clonidine 2 microgram/kg.  
LEE et  al  have also confirmed significantly  longer sedation when clonidine 2 
microgram/kg was used.  At no time in this study, was there a decrease in respiratory 
rate  and  fall  in  oxygen  saturation  (SpO
2
)  requiring  oxygen  supplementation.   The 
findings of the  present study are consistent with the findings of  JAMALI et al who 
found no significant sedation with clonidine in the doses of 1microgram/kg.
                                 XII. SUMMARY
In a randomized double blind study, we have examined the analgesic efficacy of 
caudal bupivacaine alone or a mixture of bupivacaine – clonidine in forty children (ASA 
I,II) aged 2 to 8 years undergoing lower  abdominal surgeries.  They were randomly 
allocated into two groups (n-20) to receive a  caudal  injection of  0.25% bupivacaine 
alone or a mixture of 0.25% bupivacaine with 1 microgram/kg clonidine.  Monitoring of 
scores for pain and sedation were performed by anaesthesiologists blinded to the study 
allocations.  Time to the first analgesic administration (Syrup paracetamol) was longer 
(p<0.05) with mean duration of analgesia of 10.2 hours in the bupivacaine – clonidine 
group than in the bupivacaine only group (mean duration of 4.3 hours).  In both the 
groups, there was no significant change in the heart rate and mean arterial pressure from 
the baseline value, both in the intraoperative and in the postoperative period (p>0.05). 
Though  group  BC  (bupivacaine  with  clonidine)  had  significant  sedation  score  as 
compared to group B (bupivacaine), at no time during the study period, were the patients 
deeply sedated requiring oxygen supplementation.
XIII.CONCLUSION
This study concludes that the addition of clonidine in the doses of 1microgram/kg 
to  0.75ml/kg  of  0.25%  bupivacaine  for  caudal  blockade  significantly  prolongs  the 
duration of analgesia in pediatric patients. 
 This dose is safe for use in pediatric patients without any additional risk.
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XV.PROFORMA
NAME AGE SEX WT IPNO
ASA PHYSICAL STATUS:
HISTORY
PR BP CVS RS
OTHERS
INVESTIGATIONS
HB% TC DC
BLOOD GP&Rh typing   OTHERS
DIAGNOSIS
SURGICAL PROCEDURE :
CAUDAL ADMINISTRATION
TIME
DRUG
VOLUME
SEDATION SCORE
ALDRETES SCORING
DURATION OF ANALGESIA
RESCUE ANALGESIC DRUG USED
COMPLICATIONS
DROWSINESS
HYPOTENSION
BRADYCARDIA
XVI.MASTERCHARTS
GROUP B
No Name AgeYrs Sex
Wt
Kgs
Duration of analgesia 
Hrs
1. Rajbabu 3 M 15 4
2. Prasanth 3 M 16 4
3. Viknesh 3 M 17 3
4. Abirami 3 F 18 4
5. Priyadarshini 3 F 17 5
6. Chitra 4 F 21 4
7. Ezhilarasan 4 M 25 3
8. Omprakash 4 M 17 5
9. Vishnu 4 M 12 5
10. Muthukumar 5 M 24 4
11. Jagadesh 5 M 26 4
12. Praveen 5 M 23 5
13. Valli 5 F 28 5
14. Kamatchi 6 F 28 5
15. Lakshmi 6 F 25 4
16. Ajith 6 M 26 5
17. Praveen 6 M 16 3
18. Prakash 7 M 28 5
19. Sanjay 7 M 25 5
20. Nirmala 7 M 27 4
Total
Mean
86
4.3
GROUP BC
No Name
Age
Yrs
Sex
Wt
Kgs
Duration of analgesia 
Hrs
1. Prathap 3 M 15 10
2. Vijay 3 M 10 12
3. Srinivasan 3 M 11 11
4. Abisek 3 M 14 10
5. Surendar 3 M 10 10
6. Senthikumar 4 M 13 9
7 Srimathy 4 F 13 10
8. Abirami 4 F 20 12
9. Mani 5 M 23 10
10. Iswarya 5 F 15 11
11. Prasad 6 M 18 10
12. Manikandan 6 M 18 12
13. Bhuvaneshwari 6 F 15 9
14. Iniyan 6 M 18 9
15. Chandru 7 M 25 9
16. Kathiravan 7 M 24 9
17. Parthiban 7 M 25 10
18. Saran 7 M 25 10
19. Saranya 7 F 25 9
20. Archana 7 F 23 11
Total
Mean
204
10.2
